Christopher S. Coffey

10.1k total citations · 2 hit papers
71 papers, 4.5k citations indexed

About

Christopher S. Coffey is a scholar working on Neurology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Christopher S. Coffey has authored 71 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Neurology, 13 papers in Cardiology and Cardiovascular Medicine and 10 papers in Epidemiology. Recurrent topics in Christopher S. Coffey's work include Parkinson's Disease Mechanisms and Treatments (23 papers), Neurological disorders and treatments (17 papers) and Blood Pressure and Hypertension Studies (7 papers). Christopher S. Coffey is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (23 papers), Neurological disorders and treatments (17 papers) and Blood Pressure and Hypertension Studies (7 papers). Christopher S. Coffey collaborates with scholars based in United States, Canada and Germany. Christopher S. Coffey's co-authors include Brian L. Hoh, Alexander A. Khalessi, Chelsea S. Kidwell, Karen C. Johnston, William J. Powers, Bruce Ovbiagele, Colin P. Derdeyn, James F. Meschia, S. Claiborne Johnston and Edward C. Jauch and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Christopher S. Coffey

68 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment

2015 1.6k citations William J. Powers, Colin P. Derdeyn et al. Stroke profile →
Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial

2013 481 citations Oscar Benavente, Christopher S. Coffey et al. The Lancet profile →

Peers

Christopher S. Coffey

EPIDE

NEURO

PRM

CCM

Karl Bjørnar Alstadhaug Norway

Moon‐Ku Han South Korea

Manuel Quintana Spain

Keun‐Sik Hong South Korea

Nerses Sanossian United States

L. Scott Janis United States

Brett Cucchiara United States

Deidre Anne De Silva Singapore

Christian Foerch Germany

José G. Merino United States

Karl Bjørnar Alstadhaug Norway

Christopher S. Coffey

2.0k ×1.1

EPIDE

963 ×0.5

NEURO

1.1k ×1.2

PRM

706 ×1.1

CCM

382 ×0.8

Citations per year, relative to Christopher S. Coffey Christopher S. Coffey (= 1×) peers Karl Bjørnar Alstadhaug

Countries citing papers authored by Christopher S. Coffey

Since Specialization

Citations

This map shows the geographic impact of Christopher S. Coffey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher S. Coffey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher S. Coffey more than expected).

Fields of papers citing papers by Christopher S. Coffey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher S. Coffey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher S. Coffey. The network helps show where Christopher S. Coffey may publish in the future.

Co-authorship network of co-authors of Christopher S. Coffey

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher S. Coffey. A scholar is included among the top collaborators of Christopher S. Coffey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher S. Coffey. Christopher S. Coffey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, Tammy, Ka‐Ho Wong, Lisa K. Peterson, et al.. (2025). An updated, comprehensive meta-analysis of the treatment of anti-NMDAR encephalitis: Analysis, equipoise, and the urgent need for evidence over anecdote. Journal of Neuroimmunology. 405. 578651–578651. 3 indexed citations

Ritchie, Stephen, Xia Jiang, Lisa Pennells, et al.. (2024). Cardiovascular risk prediction using metabolomic biomarkers and polygenic risk scores: a cohort study and modelling analyses. European Heart Journal. 45(Supplement_1). 2 indexed citations

Brumm, Michael C., Andrew Siderowf, Tanya Simuni, et al.. (2023). Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression. Journal of Parkinson s Disease. 13(6). 899–916. 25 indexed citations

Wong, Ka‐Ho, Gregory S. Day, Maarten J. Titulaer, et al.. (2022). The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis. Neurology. 99(23_Supplement_2). 1 indexed citations

Brown, Ethan, David Alonso–Gutiérrez, Lana M. Chahine, et al.. (2022). Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006). Neurology. 98(18_supplement). 2 indexed citations

Coffey, Christopher S., et al.. (2021). Hierarchical Bayesian clustering design of multiple biomarker subgroups (HCOMBS). Statistics in Medicine. 40(12). 2893–2921. 5 indexed citations

Picillo, Marina, David-Erick Lafontant, Susan Bressman, et al.. (2021). Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson’s Disease. Journal of Parkinson s Disease. 12(1). 421–436. 21 indexed citations

Russo, Marco J., Christina D. Orrú, Luis Concha‐Marambio, et al.. (2021). High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease. Acta Neuropathologica Communications. 9(1). 179–179. 137 indexed citations

Marek, Kenneth, Andrew Siderowf, Karl Kieburtz, et al.. (2020). PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490). Neurology. 94(15_supplement). 4 indexed citations

10.

Chahine, Lana M., Andrew Siderowf, Janel Barnes, et al.. (2019). Predicting Progression in Parkinson’s Disease Using Baseline and 1-Year Change Measures. Journal of Parkinson s Disease. 9(4). 665–679. 14 indexed citations

11.

Amara, Amy W., Lana M. Chahine, Chelsea Caspell‐Garcia, et al.. (2017). Longitudinal assessment of excessive daytime sleepiness in early Parkinson’s disease. Journal of Neurology Neurosurgery & Psychiatry. 88(8). 653–662. 75 indexed citations

12.

Pont‐Sunyer, Claustre, Eduardo Tolosa, Chelsea Caspell‐Garcia, et al.. (2017). The prodromal phase of leucine‐rich repeat kinase 2–associated Parkinson disease: Clinical and imaging Studies. Movement Disorders. 32(5). 726–738. 39 indexed citations

13.

Powers, William J., Colin P. Derdeyn, José Biller, et al.. (2015). 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment. Stroke. 46(10). 3020–3035. 1554 indexed citations breakdown →

14.

Benavente, Oscar, Christopher S. Coffey, Robin Conwit, et al.. (2013). Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. The Lancet. 382(9891). 507–515. 481 indexed citations breakdown →

15.

Carter, Barry L., Christopher S. Coffey, Liz Uribe, et al.. (2013). Similar Blood Pressure Values Across Racial and Economic Groups: Baseline Data from a Group Randomized Clinical Trial. Journal of Clinical Hypertension. 15(6). 404–412. 12 indexed citations

16.

Hines, Robert B., Chandrakumar Shanmugam, John W. Waterbor, et al.. (2009). Effect of comorbidity and body mass index on the survival of African‐American and Caucasian patients with colon cancer. Cancer. 115(24). 5798–5806. 59 indexed citations

17.

Hebert, Patricia R., Christopher S. Coffey, Daniel W. Byrne, et al.. (2008). Treatment of elderly hypertensive patients with epithelial sodium channel inhibitors combined with a thiazide diuretic reduces coronary mortality and sudden cardiac death. Journal of the American Society of Hypertension. 2(5). 355–365.e2. 9 indexed citations

18.

Asselbergs, Folkert W., Scott M. Williams, P R Hebert, et al.. (2007). Gender‐specific correlations of plasminogen activator inhibitor‐1 and tissue plasminogen activator levels with cardiovascular disease‐related traits. Journal of Thrombosis and Haemostasis. 5(2). 313–320. 40 indexed citations

19.

Qian, Han‐Zhu, Sten H. Vermund, Richard A. Kaslow, et al.. (2006). Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China. AIDS. 20(10). 1429–1435. 56 indexed citations

20.

Alexander, Dominik D., Nirag Jhala, Ellen Funkhouser, et al.. (2005). High‐grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas. Cancer. 103(10). 2163–2170. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact